GLOBAL PARACETAMOL INDUSTRY

Paracetamol is an odourless white crystalline substance that is commonly used as an over-the-counter painkiller and antipyretic in cases of mild to moderate fever. It is somewhat soluble in water and easily soluble in alcohol. It comes in a variety of forms, including tablet, capsules, liquid, soluble tablets, and injection tveins in some situations. It’s also used to make mordant blue 4 in the dye or colourant business. It also serves as an intermediary in the production of other medicinal drugs. In the agrochemical industry, paracetamol serves as an intermediary for sodium cacodylate. The Paracetamol Market is expected to increase at a CAGR of 4.3 percent over the next five years. The market’s expansion can be attributed to a variety of causes. Some of the key ones are the rising prevalence of illnesses such as headaches, flu, and the rising demand for pain management medicines. Headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains are all treated with paracetamol. It’s also a potent antipyretic that helps to lower fevers. The market is growing due to the rising burden of chronic conditions and the usage of OTC medications.

Acetaminophen (Paracetamol)

Acetaminophen, also known as paracetamol or APAP, is a pain reliever. It is a pain reliever or pain killer drug. It can also be used to cure a fever. Acetaminophen is a common painkiller with mild anti-inflammatory qualities, however it can harm the liver, blood cells, and kidneys. A benzene ring core is substituted by one hydroxyl group and the nitrogen atom of an amide group in acetaminophen. Para-aminophenol (PAP) is a final intermediary in the industrial synthesis of acetaminophen and is utilised in the production of a variety of products with uses in pharmaceuticals, dye manufacturing, and chemical manufacturing.

COVID-19 Impact on Paracetamol Industry

The pandemic of COVID-19 is predicted to have a major influence on the market. Because of its widespread availability, paracetamol has been recommended for managing fever in adults and children with COVID-19 by various healthcare authorities around the world, including the National Institute for Health and Care Excellence (NICE), the National Health Service (NHS), the CDC, and the Ministry of Health and Family Welfare (MOHFW) of the Government of India. The COVID-19 pandemic originally resulted in a surge in demand for over-the-counter analgesics like paracetamol, prompting local authorities to impose export restrictions on important pharmaceuticals while keeping adequate stock levels in their country. However, India and China export the majority of paracetamol API. According to the National Pharmaceutical Academy of France, 80 percent of the EU’s “active pharmaceutical ingredients” are imported, largely from China and India. According to the UK medicines authority, Chinese firms produce almost 40% of all APIs used worldwide. Because of the lockdown, paracetamol was in low supply in most markets throughout the world, resulting in higher prices for paracetamol tablets on the internet and in independent community pharmacies. In the midst of the COVID-19 situation, several governments promoted local paracetamol manufacture, which will increase local market participants and global competitiveness. Following the COVID-19 crisis, France, for example, intends to produce more pharmaceuticals domestically, beginning with paracetamol. On the 18th of June 2020, health minister Oliver Véran and junior economy minister Agnès Pannier-Runacher issued a joint statement stating that the government is working with French pharmaceutical companies Seqens, Upsa, and Sanofi to assure local paracetamol manufacturing and distribution. Similarly, such initiatives, collaborations, and the development of local producers are projected to have a significant impact on the global paracetamol market, resulting in its expansion.

INDIA PARACETAMOL INDUSTRY

The paracetamol market in India is predicted to develop at a rapid pace. The extensive usage of paracetamol as a first-line pain and fever reliever drives the paracetamol market in India. Furthermore, the drug’s widespread use in COVID-19-affected patients to control various symptoms of cold, cough, and fever is projected to boost market expansion. Furthermore, supportive government policies and schemes such as Pharma Vision 2020, the construction of Bulk Drug Parks, and the Production linked incentive programme for domestic bulk drug production are likely to generate attractive prospects for market growth in the coming years.

TOP PLAYERS WORLDWIDE

• Anhui BBCA Likang
• Anhui Fubore
• Anhui Topsun
• Anqiu Lu’an
• Atabay
• CFL Pharmaceuticals Limited
• Changshu Huagang
• Cipla Limited
• Reddy’s Laboratories
• Farmson Pharmaceutical Gujarat Private Limited
• GlaxoSmithKline Pharmaceuticals Ltd.
• Granules India Limited
• Hebei Jiheng
• Huzhou Konch
• Mallinckrodt
• Mallinckrodt Pharmaceuticals
• Novacyl
• Sanofi India Limited
• Sino Chemical
• SKPL
• Sri Krishna Pharmaceuticals Limited
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceuticals USA, Inc.
• Vaishali Pharma Limited
• Zhejiang Kangle